U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts

Dec.05.2024
U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts
2Firsts CEO Alan Zhao Analyzes the Direction of U.S. E-Cigarette Regulations and Their Impact on China's Supply Chain, Calling for Greater Emphasis on Compliance and Accelerated Elimination of Non-Compliant Businesses.

By Alan Zhao, CEO of 2Firsts

Disclaimer: The views expressed here are the author's own.

 

U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts
Alan Zhao Co-founder & CEO of 2Firsts

 

On December 2, a key U.S. lawmaker announced sweeping new measures to combat youth vaping, including an investigation into Chinese illicit e-cigarette manufacturers. Given the congressman's prominent role in U.S.-China trade relations and his past influence on vaping regulations, this move signals the onset of a regulatory storm. The implications are expected to be far-reaching, potentially reshaping U.S. e-cigarette markets and triggering significant shifts across China's e-cigarette supply chain.

 

 

The Politicization of E-Cigarettes

 

 

U.S. Representative Raja Krishnamoorthi, Ranking Member of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party, issued a statement calling for new measures to address youth vaping, including a fresh investigation into Chinese illicit e-cigarette manufacturers. While U.S. politicians have previously spoken on vaping regulation, Krishnamoorthi's remarks carry exceptional weight.

 

First, his role is significant. As a senior member of a congressional committee focusing on U.S.-China relations, Krishnamoorthi's actions reflect the elevated importance of this issue in U.S. politics and its connection to broader U.S.-China dynamics.

 

Second, his public statement during an NBC interview-calling for a clear message to illicit vape manufacturers that "our kids are not for sale" - underscores his resolve to take decisive action. Such a commitment from a politician of his stature makes inaction or failure politically untenable.

 

Finally, Krishnamoorthi's track record in vaping oversight is notable. Congress highlighted his leadership in a 2019 investigation into JUUL's youth-targeted marketing and his co-chairmanship of the bipartisan Congressional Caucus to End the Youth Vaping Epidemic. The case of JUUL, once valued at $38 billion, serves as a cautionary tale of regulatory fallout.

 

Krishnamoorthi's campaign reflects a broader trend of politicizing e-cigarette issues internationally. In 2024, Australia set a precedent by addressing illicit vaping through diplomatic collaboration with China. The inclusion of such measures in the joint statement by the two countries' leaders underscores the growing intergovernmental focus on this issue.

 

If the U.S. adopts a similarly political and diplomatic approach to vaping enforcement, it could set a global precedent, further intensifying regulatory scrutiny on China's e-cigarette supply chain.

 

 

Major Changes Loom for the U.S. Market

 

 

The confluence of political attention, commitment, and experience suggests sweeping changes are coming to U.S. vaping regulation. These shifts will inevitably ripple through the global industry, particularly affecting China's e-cigarette supply chain.

 

The U.S. is the world's largest vaping market and a key destination for Chinese manufacturers and brands. In recent years, the U.S. market has boomed, driven by disposable e-cigarettes. Despite FDA's Premarket Tobacco Product Application (PMTA) requirements, enforcement challenges have fostered a gray market where compliant products make up only 13.7% of sales.

 

While regulatory gaps have allowed unapproved products to dominate, Krishnamoorthi's efforts could close those gaps. By leveraging political and diplomatic tools, enforcement could extend beyond U.S. borders, targeting supply chains in China. This would mark an unprecedented escalation in regulatory oversight.

 

Currently, many noncompliant e-cigarettes enter the U.S. through "gray channels," involving legal export declarations from China but illicit import processes in destination markets. China's domestic enforcement has improved significantly, requiring manufacturers to print license numbers on packaging and comply with export regulations. However, without international cooperation, monitoring the entire supply chain remains challenging.

 

Should regulatory collaboration between the U.S. and China advance, tracing illegal sales back to manufacturers could become feasible. Such developments would severely limit companies' ability to evade accountability through tactics like changing brand names or entities.

 

 

Reflection: Compliance as a Matter of Survival

 

 

Krishnamoorthi's announcement should prompt self-reflection among China's e-cigarette industry. How did a sector initially aimed at tobacco harm reduction become a target of global criticism? The label "made in China" frequently accompanies reports on illicit vaping products in Western media.

 

You could argue this reflects a bias. However, as Krishnamoorthi once again points the finger at Chinese illicit vape manufacturers, shouldn't industry stakeholders pause for self-reflection? In the context of the already complex and delicate U.S.-China relationship, if the issue of illicit e-cigarettes further exacerbates tensions, what does this say about the industry's sense of responsibility?

 

The gray market for e-cigarettes in the United States stems from a complex web of factors. Yet, when unscrupulous actors within the industry flood the American market with wave after wave of illicit products-some resembling toys and lacking even basic child safety protections-did they not foresee the consequences we are witnessing today?

 

Through their unregulated practices, rogue operators and illicit products have secured fleeting profits, only to leave the broader Chinese e-cigarette industry and global consumers footing the bill. How much longer must this deeply unfair reality persist? How much longer can an entire industry and its consumers shoulder the costs of greed and irresponsibility?

 

Moreover, advancements in e-cigarette manufacturing technology have enabled prominent companies to set up production facilities abroad, as detailed in several 2Firsts reports. This shift is also driving the gradual relocation of associated supply chains. Emerging hubs, like those in Indonesia, are forming a nascent "non-China e-cigarette supply chain," signaling that e-cigarette production is no longer confined to China. Without proactive compliance efforts to meet international regulatory standards, China's e-cigarette supply chain risks losing its dominant position as the global center shift that could fundamentally alter the industry's landscape.

 

 

Compliance: A Catalyst for Sustainable Growth

 

 

Crackdowns on non-compliant brands, manufacturers, and distributors undoubtedly pose substantial short-term challenges for the supply chain. Yet, these measures also lay the groundwork for a more regulated market, offering a vital lifeline to compliant brands and enterprises. Historically, the prevalence of "bad money driving out good" has stifled compliant businesses, making it difficult for them to compete. Establishing a framework that rewards compliance could reverse this dynamic, paving the way for sustainable growth and incentivizing further investments in adherence to regulatory standards.

 

As pivotal actors in the supply chain, brands and manufacturers that embrace compliance can catalyze similar practices among upstream suppliers and downstream distributors. This could foster a virtuous cycle of development that spans the entire ecosystem - from Chinese production facilities to global consumer markets. If realized, such a transformation would position the industry on a path toward more sustainable, equitable, and long-term growth.

 

 

E-Cigarettes Need "Patient Capital"

 

 

More than two decades ago, the e-cigarette was invented in China. Today, the Shenzhen Greater Bay Area, often referred to as the "Fog Valley," has become the epicenter of the global e-cigarette industry, producing over 90% of the world's supply. This unparalleled dominance has cemented China's position as the backbone of the global e-cigarette supply chain—a role widely recognized and respected by international markets. Yet, as the saying goes, "Heavy is the head that wears the crown." While the industry enjoys this well-earned prestige, it must also endure the scrutiny and challenges posed by global markets.

 

Currently, new tobacco products have replaced less than 10% of traditional tobacco consumption worldwide. From the perspective of harm reduction, this underscores vast untapped potential, with the global new tobacco industry poised for exponential growth. The opportunities ahead represent a market valued in the hundreds of billions of dollars, creating fertile ground for what can be described as "patient capital." While commercial competition remains fierce and unpredictable, the risks of regulatory non-compliance are unequivocal—companies failing to meet standards face inevitable elimination.

 

For China's supply chain enterprises, as well as global brands and distributors, the path forward necessitates an unwavering commitment to compliance. This means taking responsibility for aligning with regulatory frameworks and addressing the needs of consumers seeking safer alternatives to traditional tobacco. Adopting a long-term vision, stakeholders must balance survival with adherence to compliance. Greater investment in regulatory alignment will not only enhance the standards of the global industry but also contribute significantly to the shared goal of tobacco harm reduction, fostering high-quality development and progress across the sector.

 

For comments, corrections, or additional insights, please contact alan@2firsts.com

 

Cover image source: ChatGPT

UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
BAT Adds Former Apple General Counsel Bruce Sewell to Board as Finance, Legal, Marketing and Regional Leadership Shift
BAT Adds Former Apple General Counsel Bruce Sewell to Board as Finance, Legal, Marketing and Regional Leadership Shift
British American Tobacco has appointed former Apple Senior Vice President, General Counsel and Secretary Bruce Sewell as an independent non-executive director, effective January 1, 2027. He will also join BAT's Audit and Nominations Committees. BAT Chair Luc Jobin highlighted Sewell's experience in technology, government and regulatory affairs, public-company governance and AI-company boards. Over the past 18 months, BAT has changed or announced changes to its CFO, general counsel, CMO and APMEA regional leadership, while the main board has also seen multiple changes. The appointment comes as BAT advances Horizon 2030 and its Fit2Win transformation while expanding New Categories and reshaping parts of its digital, technology and operating structure.
Business
Oct.29
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11